Could your own fat cells fix your hip pain? early trial launches

NCT ID NCT03608579

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether injecting a person's own fat-derived stem cells into a painful arthritic hip is safe and might reduce pain. Researchers at Mayo Clinic are enrolling 24 adults aged 18-65 with hip osteoarthritis. The main goal is to check for side effects, while also measuring changes in pain and activity levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

a person's own fat-derived stem cells (mesenchymal stromal cells)

What this could lead to

If it works, this could point toward a non-surgical way to reduce hip pain and improve activity for people with osteoarthritis.

What could go wrong

This is a very early Phase 1 safety trial with only 24 people. It is not designed to prove the treatment works, and the stem cell approach may not provide lasting pain relief or could cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States